“Amid an increasing focus on complex modalities and accelerated timelines within the pharmaceutical industry, the importance of CDMOs in drug development and manufacturing is growing. In this complex landscape, technology transfer provides a framework for leveraging the expertise of CDMOs, facilitating the scalable development of new products and processes and allowing organizations to build expertise, avoid mistakes, and enable more efficient development processes. Built upon a seamless flow of information from the research and development phase to operations, the technology transfer process acts as a two-way channel between research and development and operations and between external pharmaceutical companies and CDMOs.”
Veranova’s Global VP, Chemical Development Operations, Will Sanders explores the pivotal role of technology transfer in an article in BioProcess International. He discusses technology transfer at various stages, from preclinical through to commercialization, and highlights how close collaboration between CDMOs and drug developers enables seamless transitions between development phases ultimately supporting a more efficient and cost-effective process.
Read article in BioProcess International
